Market Exclusive

Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Submission of Matters to a Vote of Security Holders

Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07

Submission of Matters to a Vote of Security
Holders.

On May 23, 2017, Amyris,Inc. (the
Company) held its 2017 Annual Meeting
of Stockholders (the Annual Meeting)
for the following purposes:

To elect the four Class I directors nominated by the Companys
Board of Directors (the Board) to
serve on the Board for a three-year term
(Proposal 1).
To ratify the appointment of PricewaterhouseCoopers LLP as
the Companys independent registered public accounting firm
for the fiscal year ending December 31, 2017
(Proposal 2).
To approve, on a non-binding advisory basis, the compensation
of the Companys named executive officers as disclosed in the
Companys definitive proxy statement for the Annual Meeting
filed with the Securities and Exchange Commission on April
27, 2017 (the stockholder say-on-pay
vote
) (Proposal 3).
To hold a non-binding advisory vote regarding the frequency
of future stockholder say-on-pay votes (every one, two or
three years) (Proposal 4).
To re-approve the performance factors set forth in the
Companys 2010 Equity Incentive Plan for purposes of Section
162(m) of the Internal Revenue Code (Proposal
5
).
To approve an amendment to the Companys certificate of
incorporation to effect, at the discretion of the Board, a
fifteen-to-one reverse stock split of all of the outstanding
shares of the Companys common stock, par value $0.0001 per
share (Common Stock)
(Proposal 6).
Subject to the approval of Proposal 6, to approve an
amendment to the Companys certificate of incorporation to
effect, at the discretion of the Board, a reduction in the
total number of authorized shares of Common Stock from
500,000,000 to 250,000,000 (Proposal
7
).
To act upon such other matters as may properly come before
the Annual Meeting or any adjournments or postponements
thereof.

The following Class I directors listed in Proposal 1 were elected
to the Board based on the following votes:

For Withhold Broker Non-Vote
Geoffrey Duyk 175,083,068 2,267,389 61,967,738
Carole Piwnica 176,071,043 1,279,414 61,967,738
Fernando Reinach 176,845,139 505,318 61,967,738
HH Sheikh Abdullah bin Khalifa Al Thani 120,261,357 57,089,100 61,967,738

Proposal 2 was approved by the following vote:

For Against Abstain Broker Non-Vote
236,781,530 508,400 2,028,265

Proposal 3 was approved by the following vote:

For Against Abstain Broker Non-Vote
176,016,027 1,194,730 139,700 61,967,738

The every three years option in Proposal 4 was approved by the
following vote:

One Year Two Years Three Years Abstain Broker Non-Vote
58,524,756 10,441,007 107,916,444 468,250 61,967,738

Proposal 5 was approved by the following vote:

For Against Abstain Broker Non-Vote
174,827,146 2,143,500 379,811 61,967,738

Proposal 6 was approved by the following vote:

For Against Abstain Broker Non-Vote
219,285,869 15,800,440 417,135

Proposal 7 was approved by the following vote:

For Against Abstain Broker Non-Vote
175,848,276 1,279,895 222,286 61,967,738

No further business was brought before the Annual Meeting.

About Amyris, Inc. (NASDAQ:AMRS)
Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product. Amyris, Inc. (NASDAQ:AMRS) Recent Trading Information
Amyris, Inc. (NASDAQ:AMRS) closed its last trading session down -0.001 at 0.271 with 3,166,447 shares trading hands.

Exit mobile version